Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan
Clinical trial NCT01389687 · COMPLETED
Trial details
- NCT number
- NCT01389687
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-01-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.